These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 15057660)

  • 21. A novel mutation in the GDAP1 gene is associated with autosomal recessive Charcot-Marie-Tooth disease in an Amish family.
    Xin B; Puffenberger E; Nye L; Wiznitzer M; Wang H
    Clin Genet; 2008 Sep; 74(3):274-8. PubMed ID: 18492089
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Murine therapeutic models for Charcot-Marie-Tooth (CMT) disease.
    Fledrich R; Stassart RM; Sereda MW
    Br Med Bull; 2012 Jun; 102():89-113. PubMed ID: 22551516
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antiprogesterone therapy uncouples axonal loss from demyelination in a transgenic rat model of CMT1A neuropathy.
    Meyer zu Horste G; Prukop T; Liebetanz D; Mobius W; Nave KA; Sereda MW
    Ann Neurol; 2007 Jan; 61(1):61-72. PubMed ID: 17262851
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Charcot-Marie-Tooth disease.
    Buteică E; Roşulescu E; Stănoiu B; Burada F; Stănoiu C; Zăvăleanu M
    Rom J Morphol Embryol; 2008; 49(1):115-9. PubMed ID: 18273515
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Therapeutic options in Charcot-Marie-Tooth diseases.
    Mathis S; Magy L; Vallat JM
    Expert Rev Neurother; 2015 Apr; 15(4):355-66. PubMed ID: 25703094
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reliability and validity of the CMT neuropathy score as a measure of disability.
    Shy ME; Blake J; Krajewski K; Fuerst DR; Laura M; Hahn AF; Li J; Lewis RA; Reilly M
    Neurology; 2005 Apr; 64(7):1209-14. PubMed ID: 15824348
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Charcot-Marie-Tooth (CMT) disease 1A with superimposed inflammatory polyneuropathy in children.
    Desurkar A; Lin JP; Mills K; Al-Sarraj S; Jan W; Jungbluth H; Wraige E
    Neuropediatrics; 2009 Apr; 40(2):85-8. PubMed ID: 19809938
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A clinical review of Charcot-Marie-Tooth.
    Garcia CA
    Ann N Y Acad Sci; 1999 Sep; 883():69-76. PubMed ID: 10586233
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical and genetic description of a family with Charcot-Marie-Tooth disease type 1B from a transmembrane MPZ mutation.
    Eggers SD; Keswani SC; Melli G; Cornblath DR
    Muscle Nerve; 2004 Jun; 29(6):867-9. PubMed ID: 15170620
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The neurofilament light chain gene (NEFL) mutation Pro22Ser can be associated with mixed axonal and demyelinating neuropathy.
    Bhagavati S; Maccabee PJ; Xu W
    J Clin Neurosci; 2009 Jun; 16(6):830-1. PubMed ID: 19286384
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Identification of a new genetic entity in the form of an autosomal dominant axonal Charcot-Marie-Tooth disease associated with periodic paralyses and pyramidal syndrome].
    Chokri B; Salem M; Faycel H
    Tunis Med; 2005 Sep; 83(9):547-55. PubMed ID: 16383201
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mutation analysis of the small heat shock protein 27 gene in chinese patients with Charcot-Marie-Tooth disease.
    Tang B; Liu X; Zhao G; Luo W; Xia K; Pan Q; Cai F; Hu Z; Zhang C; Chen B; Zhang F; Shen L; Zhang R; Jiang H
    Arch Neurol; 2005 Aug; 62(8):1201-7. PubMed ID: 16087758
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of the cavus foot. Deformity in the pediatric patient with Charcot-Marie-Tooth.
    Olney B
    Foot Ankle Clin; 2000 Jun; 5(2):305-15. PubMed ID: 11232232
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Disorders of pulmonary function, sleep, and the upper airway in Charcot-Marie-Tooth disease.
    Aboussouan LS; Lewis RA; Shy ME
    Lung; 2007; 185(1):1-7. PubMed ID: 17294338
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Autosomal recessive axonal Charcot-Marie-Tooth disease (ARCMT2): phenotype-genotype correlations in 13 Moroccan families.
    Bouhouche A; Birouk N; Azzedine H; Benomar A; Durosier G; Ente D; Muriel MP; Ruberg M; Slassi I; Yahyaoui M; Dubourg O; Ouazzani R; LeGuern E
    Brain; 2007 Apr; 130(Pt 4):1062-75. PubMed ID: 17347251
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of gait parameters in patients with Charcot-Marie-Tooth disease.
    Kuruvilla A; Costa JL; Wright RB; Yoder DM; Andriacchi TP
    Neurol India; 2000 Mar; 48(1):49-55. PubMed ID: 10751814
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical, electrophysiological and molecular genetic studies in a family with X-linked dominant Charcot-Marie-Tooth neuropathy presenting a novel mutation in GJB1 Promoter and a rare polymorphism in LITAF/SIMPLE.
    Beauvais K; Furby A; Latour P
    Neuromuscul Disord; 2006 Jan; 16(1):14-8. PubMed ID: 16373087
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Update on Charcot-Marie-Tooth disease.
    Patzkó A; Shy ME
    Curr Neurol Neurosci Rep; 2011 Feb; 11(1):78-88. PubMed ID: 21080241
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Charcot-Marie-Tooth disease and pathways to molecular based therapies.
    Harel T; Lupski JR
    Clin Genet; 2014 Nov; 86(5):422-31. PubMed ID: 24697164
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pediatric orthopedic conditions in Charcot-Marie-Tooth disease: a literature review.
    Yagerman SE; Cross MB; Green DW; Scher DM
    Curr Opin Pediatr; 2012 Feb; 24(1):50-6. PubMed ID: 22189393
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.